维普中文期刊产品整合服务
51篇 您的检索式:作者名="Hassman"
    题名 作者 年代 出处 被引量
1Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue显示文摘Ninan PT Hassman HA Giass SJ 2004J Clin Psychiatry2004,65,3:1
2Pulmonary chemokine expression is coordinately regulated by STAT1,STAT6,and IFN-gamma显示文摘Fulkerson PC Zimmermann N Hassman LM Finkelman FD Rothenberg ME 0,,:1
3The effects of chronic otitismedia with effusion on the measurement of distortion products of otoacoustic emissions:presurgical and postsurgical examination显示文摘Topolska M M Hassman E Baczek M 2000Clin Otolaryngol2000,25,9:1
4The effects of chronic otitis media with effusion on the measurement of distortion products of otoacoustic emissions:presurgical and postsurgical examination显示文摘Topolska MM Hassman E Baczek M 2000Clin Otolaryngol2000,25,:1
5Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SO- LAR trial显示文摘Insull W Jr Ghali JK Hassman DR 2007Mayo Clin Proc2007,82,5:1
6Persistent effects induced by IL-13 in the lung 显示文摘Fulkerson PC Fischetti CA Hassman LM et ol 2006Am J Respir Cell Mol Biol2006,35,3:1
7The effects of chronic otitis media with effusion on the measurement of distortion products of otoacoustic emissions : presurgical and postsurgi- cal examination显示文摘Topolska MM Hassman E Baczek M 2000Clin Otolaryngol2000,,:1
8Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial 显示文摘Melani L Mills R Hassman D 2003Eur Heart J2003,24,8:1
9Efficacy and safety ofezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia:a prospective,randomized,double-blind trial显示文摘Melani L Mills R Hassman D 0,,08:1
10The effects of chronic otitis media with effusion on the measurement of distortion prod- ucts of otoacoustic emissions : presurgical and postsurgical exam- ination显示文摘Topolska MM Hassman E Baczek M 2000Clin Otolaryngol Allied Sci2000,25,4:1
11Repaglinnide versus nateglinide monotherapy:arandomized,multicenter study显示文摘Rosenstock J Hassman DR Madder RD 2004Diabetes Care2004,24,6:1
12The age of apol- agy : Facing up to the past 显示文摘Gibney M Howard - Hassman R E Coicaud J 2008International Journal of Transitional Justice2008,,2:1
13The effect of occupational exposure to styrene on the metabolism of lipids and lipoproteins 显示文摘BURESOVA E ZADAK Z HASSMAN P 1991Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl1991,34,3:1
14Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized,double - blind trial显示文摘 Mills R Hassman D 2003Eur Heart J2003,24,8:1
15The effects of chronic otitis media with effusion on the measurement of distortion products of otoacoustic emissions: presurgical and postsurgical examination 显示文摘Topolska MM Hassman E Baczek M 2000Clin Otolaryngol2000,25,:1
16Efficacy and safety of rosuvastatincompared with pravastatin and simvastatin in patients with hypercholesterolemia:a randomized, double -- blind, 52 -- week trial显示文摘Brown WV Bays HE Hassman DR 2002Am Heart J2002,144,6:1
17Repaglinide versus nateglinide monotherapy : a randomized, multicenter study 显示文摘Rosenstock J Hassman DR Madder RD 2004Diabetes Care2004,27,6:1
18Efficacy and safety of ezetimibe coadministcred with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, doubleblind trial 显示文摘MELANI L MILLS R HASSMAN D 2003Eur Heart J2003,24,8:1
19Repaglinide ver-sus nateglinide monotherapy:a randomized multicenter study显示文摘 Hassman DR Madder RD 2004Diabetes Care2004,27,6:1
20Repaglinide versus nateglinide monotherapy:a randomized,multicenter study显示文摘Rosenstock J Hassman DR Madder RD 2004Diabetes Care2004,27,6:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费